Learn two practical strategies that can help you feel more confident and informed when negotiating your next car purchase. Which tip will you try first? One Fernando Mendoza throw may have clinched ...

The period between Black Friday and New Year's Day is traditionally one of the best times to buy a new car due to year-end sales targets. Factors like tariffs, supply chain issues, and the expiration ...

The period between Black Friday and New Year's Day is traditionally one of the best times to buy a new car due to year-end sales targets. Factors like tariffs, supply chain issues, and the expiration ...

PHOENIX (KPHO/Gray News) - An Arizona father at the center of a high-profile case regarding the death of his young daughter has died. The Maricopa County Medical Examiner’s Office confirmed that ...

Christopher Scholtes, 38, previously rejected a plea deal that would have resulted in less jail time than the deal he agreed to this week. Chris Spargo is a senior reporter at PEOPLE who joined the ...

Driver signing season is in full swing as NASCAR teams keep announcing new additions to their line ups for the 2026 season. Niece Motorsports entered the movement on Wednesday by signing 2025 CARS ...

The only fun part about buying a new car is driving it off the lot. Everything else, from the negotiation to the constant phone calls and emails, can range from annoying to overwhelming. But a D.C.

Shares of Mister Car Wash (NASDAQ:MCW) jumped higher on Monday, reflecting speculation that the company is considering its strategic options. According to sources cited by The Deal, the Tucson, ...

Gilead Sciences' Kite Pharma is doubling down on in vivo CAR-T, this time inking a deal worth up to $1.64 billion biobucks with Chinese biotech Pregene Biopharma. Kite has paid out $120 million ...

TUCSON, Ariz (KGUN) — It looks like a second attempt for a plea deal has fallen through in the case of a father charged with murder after his two year old daughter died after being left in a hot car.

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...